Company: BLNE
Filing Date: 2025-03-27
Form Type: 424B7
Source: 0001641172-25-000822
Chunk: 6

Company: Beeline Holdings, Inc.
Filing Date: 2025-03-27
Form: 424B7
Chunk 6
---
 business days. Prior to this letter, the Company had received the original notice of noncompliance with the Rule from Nasdaq wherein the Company had been given until February 25, 2025 to regain compliance.

The Company effected the 1:10 reverse stock split on March 12, 2025.

| S-7 |

Corporate Information

Our principal executive offices are located in Providence, Rhode Island and our telephone number is (458) 800-9154. Our Internet website addresses are www.eastsidedistilling.com and www.makeabeeline.com. Information contained on our corporate websites does not constitute part of the prospectus supplement or the accompanying prospectus.

The Offering

| Common Stock  
 offered by us |     | Shares of common                                                                                                                    
 stock having an aggregate gross offering price of up to $3,500,000 or up to 1,666,667 shares, assuming sales at a price             
 of $2.10 per share, the last trading price of our common stock on March 26, 2025. The up to $3,500,000 of common                    
 stock to which this prospectus supplement relates is in addition to the up to $4,000,000 of common stock under the prior prospectus 
 supplements filed by the Company on March 10, 2025 and March 26, 2025 in connection with the Purchase Agreement                     
 with C/M. The actual sales prices will be based on certain factors related to our future market prices and volume. See “The         
 Purchase Agreement” at page S-10. The actual number of shares issued in connection with this offering will vary depending on        
 how many shares of common stock we choose to sell to the selling stockholder.                                                       |

| S-8 |

| Common Stock                    
 outstanding after this offering |     | 8,878,611                                                                                                                               
 shares, assuming sales at a price of $2.10                                                                                              
 per share. This amount does not include other sales of up to $4,000,000 of common stock under the prior prospectus supplements          
 filed by the Company on March 10, 2025 and March 26, 2025 in connection with the Purchase Agreement with C/M.                           |
| Use of proceeds                 |     | We will not receive any                                                                                                                 
 proceeds from the sale of the shares of common stock by the selling stockholder pursuant to this prospectus supplement. However,        
 we may receive up to $3,500,000 from the sale of shares to the